Wu et al. [20] observed that patients whose tumours expressed a low level of TGM-3 had worse overall survival (P<0.0002) and that TGM-3 expression, by univariate and multivariate analyses, was an independent prognostic factor in patients with HNSCC. Here, TGM3 is linked to neoplasm.